Post-Operative Pain Clinical Trial
Official title:
A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injections for Post-Operative Pain Following Laparoscopic Colorectal Surgery
Verified date | March 2019 |
Source | Vivozon, Inc. |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The purpose of this Phase 2 study is to evaluate the efficacy and safety of an analgesic drug candidate, VVZ-149 Injections. The study is designed as randomized, double-blind, parallel, placebo-controlled study.
Status | Completed |
Enrollment | 60 |
Est. completion date | August 15, 2016 |
Est. primary completion date | August 2016 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years to 70 Years |
Eligibility |
Inclusion Criteria: 1. Men and women age between 18-70, inclusive. 2. Pain intensity (NRS) =4 at initial post-operative measurement in PACU. 3. Subjects undergoing planned laparoscopic colorectal surgery. 4. Ability to provide written informed consent. 5. Ability to understand study procedures and communicate clearly with the investigator and staff. 6. American Society of Anesthesiologists (ASA) risk class of I to III. Exclusion Criteria: < Surgical Factors > 1. Emergency or unplanned surgery. 2. Repeat operation (e.g., previous surgery within 30 days for same condition). 3. Cancer-related condition causing preoperative pain in site of surgery. < Subject Characteristics > 4. Women with childbearing potential (Women age 18-55 must undergo pregnancy test). 5. Women who are pregnant or breastfeeding. 6. Chronic pain diagnosis (e.g., ongoing pain at baseline with NRS = 4/10). 7. Unstable or poorly controlled psychiatric condition (e.g., untreated PTSD, anxiety, or depression) Subjects who take stable doses (same dose >30 days) of antidepressants and anti-anxiety drugs may be included. 8. Unstable or acute medical condition (e.g., unstable angina, congestive heart failure, renal failure, hepatic failure, AIDS). < Drug, Alcohol, and Pharmacological Considerations > 9. Renal or hepatic impairment. 10. History of alcohol, opiate or other drug abuse or dependence within 12 months prior to Screening (TICS alcohol/drug screen will be performed at Screening). 11. Ongoing or recent (within 30 days prior to surgery) use of steroids, opioids, or antipsychotics. 12. Alcohol consumption within 24 hours of surgery. 13. Use of nonsteroidal anti-inflammatory drugs (NSAIDs) or acetaminophen within 24 hours of surgery. 14. Use of herbal agents or nutraceuticals (i.e., chaparral, comfrey, germander, jin bu huan, kava, pennyroyal, skullcap, St. John's wort, or valerian) within 7 days prior to surgery. < Anesthetic and Other Exclusion Considerations > 15. Use of neuraxial or regional anesthesia related to the surgery. 16. Use of local anesthetic wound infiltration > 20 ml of 1% lidocaine 17. Use of ketamine, gabapentin, pregabalin, or lidocaine (>1 mg/kg) intra or peri-operatively, or within 24 hours of surgery. 18. Subjects with known allergies to hydromorphone. 19. Subjects who received another investigational drug within 30 days of scheduled surgery. 20. Subjects who have long PR (>200 msec) or prolonged QTc (> 450 msec) at Screening or on an EKG done immediately prior to dosing. |
Country | Name | City | State |
---|---|---|---|
United States | Beth Israel Deaconess Medical Center | Boston | Massachusetts |
United States | Brigham and Women's Hospital | Boston | Massachusetts |
United States | Massachusetts General Hospital | Boston | Massachusetts |
Lead Sponsor | Collaborator |
---|---|
Vivozon, Inc. |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Sum of Pain Intensity Difference over 8-hours post-dose (SPID8) | SPID8 using Numerical Pain Rating Scale (NRS, 0-10) measured up to 8 hours post-dose | 8 hours post-dose | |
Secondary | Difference of Opioid Consumption between Study Groups | 0-2, 2-4, 4-6, 6-8, 8-12, 12-16, and 16-24 hours post-dose | ||
Secondary | Change of Pain Intensity (NRS) | 9 and 24 hours post-dose | ||
Secondary | Change of Pain Relief (PR) assessed using a 6-point categorical scale | 9 and 24 hours post-dose | ||
Secondary | Comparison of Global Measurement of Subject Satisfaction between Study Groups | 8 and 24 hours post-dose | ||
Secondary | Change of Richmond Agitation-Sedation Scale | 9 and 24 hours post-dose | ||
Secondary | Change of Incidence of Postoperative Nausea and Vomiting | 8 and 24 hours post-dose |
Status | Clinical Trial | Phase | |
---|---|---|---|
Terminated |
NCT05146453 -
Sternotomies and PectoIntercostal Fascia Blocks in Fast-Track Cardiac Anesthesiology
|
Phase 4 | |
Completed |
NCT05635916 -
Trial of Liposomal Bupivacaine for TKA
|
Phase 4 | |
Recruiting |
NCT06028126 -
Superficial Parasternal Intercostal Plane Block in Cardiac Surgery Trial
|
N/A | |
Not yet recruiting |
NCT03591172 -
Using Three Different Final Irrigants and Showing Their Effects on the Success of Revascularization
|
N/A | |
Completed |
NCT01686802 -
Post-operative Oral Morphine Versus Ibuprofen
|
Phase 2 | |
Completed |
NCT01667445 -
Evaluation of the Use of Spinal Epimorph in Total Knee Arthroplasty
|
Phase 4 | |
Completed |
NCT01444924 -
Transversus Abdominis Plane Blocks for Patients Undergoing Robotic Gynecologic Oncology Surgery
|
Phase 2 | |
Completed |
NCT00830089 -
Trial of a Transversus Abdominis Plane (TAP) Block in Laparoscopic Colorectal Surgery
|
N/A | |
Completed |
NCT00968955 -
Effect of Local Infiltration Analgesia in Total Hip Arthroplasty
|
Phase 4 | |
Terminated |
NCT00875862 -
Shoulder Adhesive Capsulitis and Ambulatory Continuous Interscalene Nerve Blocks
|
Phase 4 | |
Completed |
NCT00847093 -
LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery
|
Phase 4 | |
Completed |
NCT00390312 -
Efficacy and Safety of Intranasal Morphine for Pain After Third Molar Extraction
|
Phase 2 | |
Recruiting |
NCT05278494 -
Dextromethorphan for Treatment of Postoperative Pain
|
N/A | |
Recruiting |
NCT05973045 -
Investigation of the Effect of Distention Medium Temperature on Image Quality, Hyponatremia Risk, and Post-operative Pain in Operative Hysteroscopy
|
N/A | |
Not yet recruiting |
NCT04999670 -
Fascial Closure and Post-caesarean Pain
|
N/A | |
Enrolling by invitation |
NCT04346407 -
Dronabinol for Post-operative Pain After Lumbar Fusion
|
Phase 4 | |
Completed |
NCT03635515 -
Occurrence of Post-op Pain Following Gentlewave
|
N/A | |
Terminated |
NCT03201809 -
Comparison of Preoperative Ultrasound Guided Pectoralis Nerve Block Placement Versus Intra-operative Placement: A Prospective Randomized Trial
|
N/A | |
Completed |
NCT03254056 -
Fascial Closure Techniques Post-Operative Pain Laparoscopy
|
N/A | |
Not yet recruiting |
NCT02555423 -
The Effects of Serratus Plane Block Performed Under Direct Vision on Post-operative Pain in Breast Surgery
|
N/A |